Skip to main content
Year archive

Jagsonpal Pharmaceuticals Limited — 2026 filings

All 91 regulatory filings released by Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) in 2026, sourced directly from the official regulator.

91 Filings
2026 Period
2026 filings (91)
Filing Released Lang
Copy of Newspaper Publication
Regulatory Filings
2026-05-25 English
Submission of copy of Post Buy Back Public Advertisement related to Buy back of shares of Company.
Transaction in Own Shares
2026-05-25 English
Centrum Broking Ltd ("Manager to the Buyback") has submitted to BSE a copy of Post Buyback Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares ....
Transaction in Own Shares
2026-05-25 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-18 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-18 English
Resignation
Board/Management Information
2026-05-18 English
Resignation of an Independent Director.
Board/Management Information
2026-05-18 English
Copy of Newspaper Publication
Transaction in Own Shares
2026-05-07 English
Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company
Transaction in Own Shares
2026-05-07 English
Buyback
Capital/Financing Update
2026-05-06 English
Updates
Transaction in Own Shares
2026-05-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-05-04 English
Newspaper Advertisement- Extract of Audited Financial Results for FY 26
Regulatory Filings
2026-04-29 English
Submission of Public Announcement pertaining to Buy back of Shares of Company published in the newspaper along with Board and Shareholder Resolution
Transaction in Own Shares
2026-04-29 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-29 English
Copy of Newspaper Publication
Report Publication Announcement
2026-04-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-04-28 English
Audio Recording of Jagsonpal Pharmaceuticals Limited Q4 FY26 Earnings Conference Call on April 28, 2026 at 3:00 P.M
Regulatory Filings
2026-04-28 English
Recommendation of Dividend for the financial year ended 31 March, 2026
Notice of Dividend Amount
2026-04-27 English
Record Date
Capital/Financing Update
2026-04-27 English
Intimation for Record date of Buy Back.
Capital/Financing Update
2026-04-27 English
Intimation for grant of Employee Stock Options
Capital/Financing Update
2026-04-27 English
Updates
Capital/Financing Update
2026-04-27 English
General Updates
Notice of Dividend Amount
2026-04-27 English
Press Release
Annual Report
2026-04-27 English
Press Release for Audited Results for the quarter and year ended March 31, 2026
Earnings Release
2026-04-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Annual Report
2026-04-27 English
Dividend
Annual Report
2026-04-27 English
Outcome of Board Meeting
Annual Report
2026-04-27 English
Recommendation of Dividend for the Financial Year ended March 31, 2026
Notice of Dividend Amount
2026-04-27 English
Press Release for Audited Financial Results for the quarter and year ended March 31, 2026
Interim / Quarterly Report
2026-04-27 English
Audited Financial Results along with Independent Auditor''s Review Report for the quarter and year ended March 31, 2026.
Regulatory Filings
2026-04-27 English
Outcome of Board Meeting held on April 27, 2026 along with Audited (Standalone) Financial Results for the quarter and year ended March 31, 2026
Regulatory Filings
2026-04-27 English
Press Release
Capital/Financing Update
2026-04-27 English
Voting Result of Postal Ballot along with Scrutinizer Report.
Declaration of Voting Results & Voting Rights Announcements
2026-04-27 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2026-04-27 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as ....
Regulatory Filings
2026-04-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-04-22 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-04-20 English
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Board/Management Information
2026-04-20 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2026-04-20 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-14 English
Newspaper Advertisement regarding transfer of shares to IEPF.
Regulatory Filings
2026-04-14 English
Updates
Share Issue/Capital Change
2026-04-13 English
Allotment of 1,76,900 Equity Shares under Jagsonpal Pharmaceuticals Limited Employee Stock Option, Plan 2022
Share Issue/Capital Change
2026-04-13 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026
Regulatory Filings
2026-04-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-10 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement
2026-03-26 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit copy of advertisement published in Newspaper with regard to Postal Ballot Notice sent to the Shareholders of Company.
Regulatory Filings
2026-03-26 English
Closure of Trading Window for the quarter and Financial Year Ended on March 31, 2026.
Regulatory Filings
2026-03-26 English
Trading Window
Regulatory Filings
2026-03-26 English
Shareholders meeting
Share Issue/Capital Change
2026-03-25 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, Please find attached Postal ballot Notice relating to approval for Buy back of upto Rs. 16,00,000 Equity shares of face value ....
Share Issue/Capital Change
2026-03-25 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings
2026-03-13 English
Please find attached disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2026-03-13 English
Press Release
Capital/Financing Update
2026-03-12 English
Please release on announcement of buy back of Equity shares of Company
Transaction in Own Shares
2026-03-12 English
Buyback
Capital/Financing Update
2026-03-12 English
Outcome of Board Meeting
Capital/Financing Update
2026-03-12 English
Please find attached outcome of meeting held on March 12, 2026 for consideration of buy back of equity shares.
Capital/Financing Update
2026-03-12 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-03-09 English
Board Meeting — Buyback
Capital/Financing Update
2026-03-09 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-03-09 English
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/03/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Capital/Financing Update
2026-03-09 English
Intimation for grant of employees stock option
Share Issue/Capital Change
2026-03-09 English
Updates
Share Issue/Capital Change
2026-03-09 English
Allotment of 71,800 Equity shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
Share Issue/Capital Change
2026-03-09 English
Updates
Capital/Financing Update
2026-03-09 English
Intimation for grant of Employee stock options
Capital/Financing Update
2026-03-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-01-27 English
Earnings Call Transcript for meeting held on 22 January, 2026
Call Transcript
2026-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-01-22 English
Copy of Newspaper Publication
Regulatory Filings
2026-01-22 English
Pursuant to Regulation 47 of SEBI (LODR), 2015, please find enclosed copies of advertisement published on January 22, 2026 in Business Standard (English) and Business Standard (Hindi) newspaper ....
Regulatory Filings
2026-01-22 English
Press release and investor presentation for the quarter and nine months ended December 31, 2025
Interim / Quarterly Report
2026-01-21 English
Press release and investor presentation for the quarter and nine months ended December 31, 2025
Interim / Quarterly Report
2026-01-21 English
Investor Presentation
Interim / Quarterly Report
2026-01-21 English
Press Release
Interim / Quarterly Report
2026-01-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report
2026-01-21 English
Pursuant to Regulation 33 of SEBI (LODR) 2015, we would like to inform you that the board of directors at its meeting held today, inter-alia, considered and approved the unaudited financial ....
Regulatory Filings
2026-01-21 English
Outcome of Board Meeting
Regulatory Filings
2026-01-21 English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2026-01-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-01-15 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a ....
Call Transcript
2026-01-15 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-13 English
Board Meeting — Financial Results
Regulatory Filings
2026-01-13 English
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2026-01-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-01-06 English
Pursuant to Regulation 74(5) of SEBI (DP)Regulations, 2018 we are enclosing herewith a copy of the Certificate, received from MCS Share Transfer agent limited, the RTA of Company, for the ....
Regulatory Filings
2026-01-06 English
Updates
Share Issue/Capital Change
2026-01-06 English
Allotment of 1,09,180 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
Share Issue/Capital Change
2026-01-06 English